Table 2.
Cox proportional hazards multivariable models for demographic and tumor characteristics of 601 patients with NMIBC (for Pheno age acceleration).
10-year overall survival HR (95% CI) | 10-year recurrence-free survivala HR (95% CI) | |
---|---|---|
Age | 1.08 (1.06–1.10) | 1.02 (1.01–1.03) |
Pheno age acceleration | 1.06 (1.03–1.08) | 1.02 (1.00–1.03) |
Sex | ||
Male | ||
Female | 0.50 (0.33–0.78) | |
Tumor grade | ||
Low grade | ||
High grade | 1.58 (1.15–2.17) | 1.49 (1.18–1.88) |
Smoking status | ||
Non-smoker | ||
Former-smoker | 1.35 (0.82–2.22) | 1.56 (1.13–2.15) |
Current-smoker | 1.87 (1.10–3.16) | 1.69 (1.20–2.38) |
BCG treatment | ||
No | ||
Yes | 0.89 (0.58–1.34) |
Abbreviations: CI, confidence interval; HR, hazard ratio; NMIBC, non–muscle-invasive bladder cancer.
aStratification was used on sex and BCG treatment status for proportional assumption.